Obesity, insulin resistance, and skeletal muscle nitric oxide synthase

Journal of Applied Physiology

Volumn 113, Issue 5, 2012, Pages 758-765

  Kraus, Raymond M ^a   Houmard, Joseph A ^a   Kraus, William E ^b   Tanner, Charles J ^a   Pierce, Joseph R ^a   Choi, Myung Dong ^a   Hickner, Robert C ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ENOS; INOS; Insulin resistance; Minimal model; Nitric oxide; NNOS; Obesity

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD; COHORT ANALYSIS; ENZYMOLOGY; EXERCISE TEST; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; OBESITY; PHYSIOLOGY; SKELETAL MUSCLE;

ADULT; AGED; BLOOD GLUCOSE; COHORT STUDIES; EXERCISE TEST; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OBESITY;

EID: 84865770261     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01018.2011     Document Type: Article

References (59)

1. Adams V, Nehrhoff B, Spate U, Linke A, Schulze PC, Baur A, Gielen S, Hambrecht R, Schuler G. Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study. Cardiovasc Res 54: 95-104, 2002. (Pubitemid 34327940)
2. Agusti A, Morla M, Sauleda J, Saus C, Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 59: 483-487, 2004. (Pubitemid 38797520)
3. Aldridge GM, Podrebarac DM, Greenough WT, Weiler IJ. The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods 172: 250-254, 2008.
4. Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM. Increased p85/ 55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 54: 2351-2359, 2005. (Pubitemid 41134262)
5. Barreiro E, Comtois AS, Gea J, Laubach VE, Hussain SN. Protein tyrosine nitration in the ventilatory muscles: role of nitric oxide synthases. Am J Respir Cell Mol Biol 26: 438-446, 2002. (Pubitemid 34253928)
6. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 6: 45-86, 1985.
7. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 5: 1003-1015, 2003. (Pubitemid 38009940)
8. Bradley SJ, Kingwell BA, Canny BJ, McConell GK. Skeletal muscle neuronal nitric oxide synthase micro protein is reduced in people with impaired glucose homeostasis and is not normalized by exercise training. Metabolism 56: 1405-1411, 2007. (Pubitemid 47407755)
9. Brozinick JT Jr, Roberts BR, Dohm GL. Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance. Diabetes 52: 935-941, 2003. (Pubitemid 36384263)
10. Bugger H, Abel ED. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin Sci (Lond) 114: 195- 210, 2008. (Pubitemid 351293995)
11. Carvalho-Filho MA, Ueno M, Carvalheira JB, Velloso LA, Saad MJ. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/ IRS-1 and Akt and insulin resistance in muscle of mice. Am J Physiol Endocrinol Metab 291: E476-E482, 2006. (Pubitemid 44352252)
12. Carvalho-Filho MA, Ueno M, Hirabara SM, Seabra AB, Carvalheira JB, de Oliveira MG, Velloso LA, Curi R, Saad MJ. S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 54: 959-967, 2005. (Pubitemid 40446309)
13. Cha HN, Kim YW, Kim JY, Kim YD, Song IH, Min KN, Park SY. Lack of inducible nitric oxide synthase does not prevent aging-associated insulin resistance. Exp Gerontol 45: 711-718, 2010.
14. Charbonneau A, Marette A. Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins. Diabetes 59: 861-871, 2010.
15. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB, 3rd Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728-1731, 2001. (Pubitemid 32506248)
16. Clevenger CM, Parker Jones P, Tanaka H, Seals DR, DeSouza CA. Decline in insulin action with age in endurance-trained humans. J Appl Physiol 93: 2105-2111, 2002. (Pubitemid 35379337)
17. Cook S, Hugli O, Egli M, Vollenweider P, Burcelin R, Nicod P, Thorens B, Scherrer U. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 133: 360-363, 2003. (Pubitemid 37064561)
18. Ellger B, Langouche L, Richir M, Debaveye Y, Vanhorebeek I, Teerlink T, Van Leeuwen PA, Van den Berghe G. Modulation of regional nitric oxide metabolism: blood glucose control or insulin? Intensive Care Med 34: 1525-1533, 2008.
19. Evans WJ, Phinney SD, Young VR. Suction applied to a muscle biopsy maximizes sample size. Med Sci Sports Exerc 14: 101-102, 1982. (Pubitemid 12118274)
20. Fonseca VA, Fink LM, Kern PA. Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects. Atherosclerosis 167: 105-109, 2003. (Pubitemid 36255641)
21. Fujimoto M, Shimizu N, Kunii K, Martyn JA, Ueki K, Kaneki M. A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 54: 1340-1348, 2005. (Pubitemid 40586662)
22. Gerber NC, Nishida CR, Ortiz de Montellano PR. Characterization of human liver inducible nitric oxide synthase expressed in Escherichia coli. Arch Biochem Biophys 343: 249-253, 1997. (Pubitemid 27297588)
23. Gerber NC, Ortiz de Montellano PR. Neuronal nitric oxide synthase. Expression in Escherichia coli, irreversible inhibition by phenyldiazene, and active site topology. J Biol Chem 270: 17791-17796, 1995.
24. Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs S, Yu J, Kempf W, Schubert A, Schuler G, Hambrecht R. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 42: 861-868, 2003. (Pubitemid 37059745)
25. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95: 2195-2204, 1995.
26. Hickner RC, Kemeny G, Stallings HW, Manning SM, McIver KL. Relationship between body composition and skeletal muscle eNOS. Int J Obes (Lond) 30: 308-312, 2006. (Pubitemid 43237688)
27. Kaneki M, Shimizu N, Yamada D, Chang K. Nitrosative stress and pathogenesis of insulin resistance. Antioxid Redox Signal 9: 319-329, 2007. (Pubitemid 46145980)
28. Karlsson HK, Zierath JR, Kane S, Krook A, Lienhard GE, Wallberg- Henriksson H. Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes 54: 1692-1697, 2005. (Pubitemid 40770759)
29. Kern PA, Simsolo RB, Fournier M. Effect of weight loss on muscle fiber type, fiber size, capillarity, and succinate dehydrogenase activity in humans. J Clin Endocrinol Metab 84: 4185-4190, 1999. (Pubitemid 30644215)
30. Kim JA, Wei Y, Sowers Jr. Role of mitochondrial dysfunction in insulin resistance. Circ Res 102: 401-414, 2008. (Pubitemid 351651099)
31. Kolodziejski PJ, Rashid MB, Eissa NT. Intracellular formation of "undisruptable" dimers of inducible nitric oxide synthase. Proc Natl Acad Sci USA 100: 14263-14268, 2003. (Pubitemid 37499225)
32. Krook A, Bjornholm M, Galuska D, Jiang XJ, Fahlman R, Myers MG Jr, Wallberg-Henriksson H, Zierath Jr. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49: 284-292, 2000. (Pubitemid 30071007)
33. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, Hansen TK, Van den Berghe G. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115: 2277-2286, 2005. (Pubitemid 41134169)
34. Lillioja S, Young AA, Culter CL, Ivy JL, Abbott WG, Zawadzki JK, Yki-Jarvinen H, Christin L, Secomb TW, Bogardus C. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80: 415-424, 1987.
35. Lu M, Li P, Pferdekamper J, Fan W, Saberi M, Schenk S, Olefsky JM. Inducible nitric oxide synthase deficiency in myeloid cells does not prevent diet-induced insulin resistance. Mol Endocrinol 24: 1413-1422, 2010.
36. Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, Nissen M, Isomaa B, Forsen B, Homstrom N, Saloranta C, Taskinen MR, Groop L, Tuomi T. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54: 166-174, 2005. (Pubitemid 40105109)
37. Manetta J, Brun JF, Callis A, Mercier J, Prefaut C. Insulin and non-insulin-dependent glucose disposal in middle-aged and young athletes versus sedentary men. Metabolism 50: 349-354, 2001. (Pubitemid 32248984)
38. McConell GK, Bradley SJ, Stephens TJ, Canny BJ, Kingwell BA, Lee-Young RS. Skeletal muscle nNOS mu protein content is increased by exercise training in humans. Am J Physiol Regul Integr Comp Physiol 293: R821-R828, 2007. (Pubitemid 47205068)
39. McIver KL, Evans C, Kraus RM, Ispas L, Sciotti VM, Hickner RC. NO-mediated alterations in skeletal muscle nutritive blood flow and lactate metabolism in fibromyalgia. Pain 120: 161-169, 2006. (Pubitemid 43077179)
40. Montes de Oca M, Torres SH, De Sanctis J, Mata A, Hernandez N, Talamo C. Skeletal muscle inflammation and nitric oxide in patients with COPD. Eur Respir J 26: 390-397, 2005. (Pubitemid 41264199)
41. Nishida CR, Ortiz de Montellano PR. Electron transfer and catalytic activity of nitric oxide synthases. Chimeric constructs of the neuronal, inducible, and endothelial isoforms. J Biol Chem 273: 5566-5571, 1998. (Pubitemid 28124023)
42. Okuda S, Kanda F, Kawahara Y, Chihara K. Regulation of inducible nitric oxide synthase expression in L6 rat skeletal muscle cells. Am J Physiol Cell Physiol 272: C35-C40, 1997.
43. Perreault M, Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7: 1138-1143, 2001. (Pubitemid 33010023)
44. Punkt K, Fritzsche M, Stockmar C, Hepp P, Josten C, Wellner M, Schering S, Buchwalow IB. Nitric oxide synthase in human skeletal muscles related to defined fibre types. Histochem Cell Biol 125: 567-573, 2006. (Pubitemid 43673519)
45. Purcell TL, Buhimschi IA, Given R, Chwalisz K, Garfield RE. Inducible nitric oxide synthase is present in the rat placenta at the fetal-maternal interface and decreases prior to labour. Mol Hum Reprod 3: 485-491, 1997. (Pubitemid 127509368)
46. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med 14: 741-751, 2008.
47. Riede UN, Forstermann U, Drexler H. Inducible nitric oxide synthase in skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 32: 964-969, 1998. (Pubitemid 28459585)
48. Rodriguez-Crespo I, Ortiz de Montellano PR. Human endothelial nitric oxide synthase: expression in Escherichia coli, coexpression with calmodulin, and characterization. Arch Biochem Biophys 336: 151-156, 1996. (Pubitemid 26423761)
49. Rudnick J, Puttmann B, Tesch PA, Alkner B, Schoser BG, Salanova M, Kirsch K, Gunga HC, Schiffl G, Luck G, Blottner D. Differential expression of nitric oxide synthases (NOS 1-3) in human skeletal muscle following exercise countermeasure during 12 weeks of bed rest. FASEB J 18: 1228-1230, 2004. (Pubitemid 39561559)
50. Shankar RR, Wu Y, Shen HQ, Zhu JS, Baron AD. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 49: 684-687, 2000. (Pubitemid 30339980)
51. Slezak J, Buchwalow IB, Schulze W, Karczewski P, Wallukat G, Samoilova VE, Krause EG, Neumann J, Haller H. Cellular control of nitric oxide synthase expression and activity in rat cardiomyocytes. Antioxid Redox Signal 6: 345-352, 2004. (Pubitemid 38332592)
52. Sugita H, Fujimoto M, Yasukawa T, Shimizu N, Sugita M, Yasuhara S, Martyn JA, Kaneki M. Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J Biol Chem 280: 14203-14211, 2005. (Pubitemid 40517322)
53. Sugita M, Kaneki M, Sugita H, Tokunaga E, & Martyn Jeevendra AJ. Involvement of inducible nitric oxide synthase in stress-induced insulin resistance. Am Diabetes Assoc 66th Scientific Sessions A-411, 2006.
54. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372: 182-186, 1994. (Pubitemid 24347838)
55. Torres SH, De Sanctis JB, de LBM, Hernandez N, Finol HJ. Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients. J Endocrinol 181: 419-427, 2004. (Pubitemid 38868192)
56. Vodovotz Y, Russell D, Xie QW, Bogdan C, Nathan C. Vesicle membrane association of nitric oxide synthase in primary mouse macrophages. J Immunol 154: 2914-2925, 1995.
57. Williams G, Brown T, Becker L, Prager M, Giroir BP. Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes. Am J Physiol Regul Integr Comp Physiol 267: R1020-R1025, 1994.
58. Yasukawa T, Tokunaga E, Ota H, Sugita H, Martyn JA, Kaneki M. S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem 280: 7511-7518, 2005. (Pubitemid 40349643)
59. Yeh JI, Gulve EA, Rameh L, Birnbaum MJ. The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport. J Biol Chem 270: 2107-2111, 1995.